differences between tirzepatide and semaglutide caused roughly half as many patients to stop treatment because of gastrointestinal side effects as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Comparison of tirzepatide versus semaglutide

Greater improvements in cardiometabolic risk factors were observed with semaglutide 2.4 mg vs placebo (see Table full abstract), including blood pressure, blood fats, cholesterol and glycated haemoglobin (HbA1c a measure of blood sugar control used in diagnosis of diabetes)

it is not approved by the MHRA or EMA

Coordinating care with a healthcare professional ensures that tirzepatide fits safely into their overall treatment plan

Additionally, there are several natural treatments that may help improve anxiety symptoms

The milky, smooth texture absorbs swiftly without sticky residue perfect for sensitive skin

Myrtus: Anti-bacterial, anti-acne